# Combination Chemotherapy in Treating Children With Lymphoma

> **NCT00002590** · PHASE2 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 221 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** cyclophosphamide
- **DRUG:** cytarabine
- **DRUG:** daunorubicin hydrochloride
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide
- **DRUG:** leucovorin calcium
- **DRUG:** methotrexate
- **DRUG:** pegaspargase
- **DRUG:** prednisone
- **DRUG:** thioguanine
- **DRUG:** vincristine sulfate
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00002590
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-07
- **Primary completion:** 2001-03
- **Final completion:** 2007-03
- **Target enrollment:** 221 (ACTUAL)
- **Last updated:** 2014-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002590, "Combination Chemotherapy in Treating Children With Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00002590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*